SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-047409
Filing Date
2018-07-26
Accepted
2018-07-26 16:16:45
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14089_110q.htm 10-Q 792760
2 EX-10.81 a18-14089_1ex10d81.htm EX-10.81 4514
3 EX-10.82 a18-14089_1ex10d82.htm EX-10.82 32805
4 EX-31.1 a18-14089_1ex31d1.htm EX-31.1 9870
5 EX-31.2 a18-14089_1ex31d2.htm EX-31.2 9868
6 EX-32 a18-14089_1ex32.htm EX-32 11674
  Complete submission text file 0001104659-18-047409.txt   5267637

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT inva-20180630.xml EX-101.INS 1458633
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20180630.xsd EX-101.SCH 38824
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20180630_cal.xml EX-101.CAL 57994
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20180630_def.xml EX-101.DEF 155018
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT inva-20180630_lab.xml EX-101.LAB 331116
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20180630_pre.xml EX-101.PRE 266786
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 18971949
SIC: 2834 Pharmaceutical Preparations